Table 2.
Clinical characteristics of patients with occult hepatitis B and detectable full hepatitis B virus genome
| Sample ID | Age | Gender | Diagnosis | Anti-HBs (mIU/L) | HBV DNA Log (copies/mL) | Mutation1 |
| EGL6 | 38 | M | Malignant lymphoma | (+)/15 | 3.5 | - |
| U31 | 55 | F | Malignant lymphoma | (-) | 3.8 | S143L |
| EGL4 | 80 | F | Malignant lymphoma | (+)/18.9 | 2.4 | P120S, S143L |
| A79 | 5 | M | ALL | NT | 4.4 | P120T |
| D1 | 70 | M | Malignant lymphoma | (-) | 3.9 | P120T |
| D14 | 5 | M | HD | (-) | 3.6 | P120T |
1
Mutation in the “a” determinant region of the S gene product. ALL: Acute lymphoblastic leukemia; HD: Hodgkin disease; HBV: Hepatitis B virus; NT: Not tested; M: Male; F: Female.